Hong Kong Stock Announcement Highlights | Muyuan Foods Launches Hong Kong IPO; Sunny Optical Expects 2025 Net Profit to Surge 70%-75%

Stock News
01/29

[Major Corporate Actions] Zhenghui Medical (02677) will offer shares from January 29 to February 3, with an expected listing date of February 6. Muyuan Foods Co.,Ltd. (02714) will offer shares from January 29 to February 3, with an expected listing date of February 6. Han's CNC (03200) will offer shares from January 29 to February 3, with an expected listing date of February 6. OSL Group (00863) plans a top-up placing at a discount of approximately 17.2%, aiming to raise net proceeds of about HK$1.55 billion. Zoomlion (01157) plans to issue RMB 6 billion in convertible bonds due 2031. China Railway Signal & Communication Corp Ltd (03969) secured 21 significant projects from November to December 2025, with a total value of approximately RMB 5.26 billion. Zhida Technology (02650) established a joint venture to advance its new energy charging business and accelerate its global ecosystem layout. China Railway Group Ltd (00390) recently won several major project contracts, with a combined bid value of approximately RMB 43.292 billion.

[Financial Results] Sands China Ltd. (01928) reported total net revenue for 2025 of $7.44 billion, a 5.1% year-on-year increase. Sunny Optical (02382) issued a positive profit alert, expecting annual profit attributable to shareholders to be between approximately RMB 4.5886 billion and RMB 4.7235 billion, representing an increase of 70.0% to 75.0% year-on-year. Biocytogen (02315) released its 2025 performance forecast, anticipating a net profit attributable to owners of RMB 162 million to RMB 182 million, a surge of 384.26% to 443.88% year-on-year. WANGUO GOLD GP (03939) issued a profit alert, expecting profit attributable to company owners for 2025 to be between RMB 1.4 billion and RMB 1.5 billion, an increase of approximately 143% to 161% year-on-year. Tigermed (03347) issued a positive profit alert, expecting 2025 net profit attributable to owners to be approximately RMB 830 million to RMB 1.23 billion, a growth of 105% to 204% year-on-year. InnoCare Pharma (09969) expects a 2025 net profit attributable to owners of approximately RMB 633 million, marking its first turnaround to profitability. TIANQI LITHIUM (09696) issued a profit alert, anticipating a 2025 net profit of RMB 369 million to RMB 553 million, reversing from a loss to a profit year-on-year. GUOQUAN (02517) issued a positive profit alert, expecting to achieve a net profit of approximately RMB 443 million to RMB 463 million for 2025, an increase of about 83.7% to 92.0% year-on-year. Chunli (01858) released its 2025 performance forecast, expecting net profit attributable to owners to be between RMB 245 million and RMB 288 million, a rise of 96.01% to 130.41% year-on-year. Genesis MedTech (02190) issued a profit alert, expecting annual net profit attributable to shareholders to exceed RMB 240 million, an increase of approximately 139.4% year-on-year. Longpan Technology (02465) issued a profit warning, expecting its 2025 net loss attributable to owners to be substantially reduced to approximately RMB 180 million to RMB 148 million. China Suntien Green Energy (00956) generated a cumulative electricity output of 15.2104 million MWh in 2025, an increase of 7.71% year-on-year. China Railway Construction Corporation Limited (01186) reported new contract signings totaling RMB 3,076.497 billion for 2025, a 1.3% year-on-year increase.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10